The Pfizer COVID-19 vaccine is now the recommended shot for people under the age of 50, as health advice changed due to concerns over rare blood clotting cases in people in their 50s having their first dose of the AstraZeneca vaccine. Professor Bruce Thompson, the Dean of Health Sciences at Swinburne University, says there is an effort to maintain supply in the rollout as the change comes into effect.